An Open Label, 1-Sequence Cross-Over, Positron Emission Tomography (PET) Study With [11C]Raclopride to Determine Central D2 Dopamine Receptor Occupancy of Quetiapine Fumarate Immediate Release (SEROQUEL) With Quetiapine Fumarate Extended Release (SEROQUEL XR) in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar disorders; Depressive disorders; Generalised anxiety disorder; Personality disorders; Schizophrenia
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 15 Sep 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 15 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Feb 2009 New trial record